Literature DB >> 7453835

Hexobarbital-binding, hydroxylation and hexobarbital-dependent hydrogen peroxide production in hepatic microsomes of guinea pig, rat and rabbit.

G Heinemeyer, S Nigam, A G Hildebrandt.   

Abstract

Cytochrome P-450 dependent oxygenase (3'-hydroxy-hexobarbital) and oxidase activities (hydrogen peroxide) have been measured in hepatic microsomes from guinea pigs, rats and rabbits. A sensitive gas-chromatographic assay was developed to measure the hydroxylated product 3'-hydroxy-hexobarbital. The kinetics of its formation were determined and correlated to hexobarbital type I binding and compared with oxidase activity: in the rat, Vmax for 3'-hydroxyhexobarbital formation was 5.1 and 2.6 nmoles/mg/min, resp. This was increased by phenobarbital treated rabbits, Vmax was 15.0 nmoles/mg/min for hydroxylation and 40.8 for H2O2 formation. Spectral affinity constants (Ks) in control animals were 0.12 mM (rats) and 0.14 mM (rabbits). Phenobarbital treatment decreased these affinity constants, which were similar for each activity measured. In guinea pigs, however, hydroxylation of exobarbital was low (3.1 nmoles/mg/min) and hexobarbital-dependent formation of H2O2 was higher than hydroxylation (Vmax: 7.0 nmoles/mg/min). Phenobarbital treatment led here to two affinity constnts for each activity measured, which however, were alike. The existence of low in addition to high affinity constants observed here might explain the difficulties seen hitherto in correlating hexobarbital binding and metabolism in this species. Total oxidase activity was higher than oxygenase activity in all species tested. It is suggested that oxygenase activity of cytochrome P-450 is not limited by binding but by a competition with oxidase activity for a common intermediary species. This might be peroxy-P-450 (substrate-Fe3+O2(2-), rendering either substrate-Fe3+ O for hydroxylation reaction, or oxidized cytochrome P-450-substrate and hydrogen peroxide as product of oxidase function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7453835     DOI: 10.1007/bf00504539

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450.

Authors:  G D Nordblom; M J Coon
Journal:  Arch Biochem Biophys       Date:  1977-04-30       Impact factor: 4.013

2.  The enzymatic metabolism of hexobarbital (evipal).

Authors:  J R COOPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-08       Impact factor: 4.030

3.  [Gas chromatographic determination of hexobarbital and its metabolites in biological materials].

Authors:  H Steinbach; W Gielen
Journal:  J Chromatogr       Date:  1977-09-11

4.  Assay of hexobarbital hydroxylase.

Authors:  D Kupfer
Journal:  Drug Metab Dispos       Date:  1978 Sep-Oct       Impact factor: 3.922

5.  Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.

Authors:  R Kato; K Onoda; M Sasajima
Journal:  Jpn J Pharmacol       Date:  1970-06

6.  Metabolism and cytochrome P-450 binding spectra of (+)- and (-)-hexobarbital in rat liver microsomes.

Authors:  E Degkwitz; V Ullrich; H Staudinger
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1969-05

7.  Kinetic studies on the control of ethylmorphine N-demethylase. The role of ethylmorphine activation of reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase.

Authors:  J L Holtzman; B H Rumack
Journal:  Biochemistry       Date:  1973-06-05       Impact factor: 3.162

8.  Pharmacokinetics of the enantiomers of hexobarbital studied in the same intact rat and in the same isolated perfused rat liver.

Authors:  D D Breimer; J M van Rossum
Journal:  Eur J Pharmacol       Date:  1974-05       Impact factor: 4.432

9.  A sensitive radioactive assay for hexobarbital hydroxylase in hepatic microsomes.

Authors:  D Kupfer; J Rosenfeld
Journal:  Drug Metab Dispos       Date:  1973 Nov-Dec       Impact factor: 3.922

10.  Metabolism of drugs. VI. The metabolic fate of methylhexabital (5-cyclohexenyl-3, 5-dimethylbarbituric acid). 2. On the chromic oxidation of methylhexabital and normethylhexabital (5-cyclohexenyl-5-methylbarbituric acid).

Authors:  S TOKI; H TSUKAMOTO; H YOSHIMURA
Journal:  Pharm Bull       Date:  1956-10
View more
  3 in total

1.  Dependence of hydrogen peroxide formation in rat liver microsomes on the molecular structure of cytochrome P-450 substrates: a study with barbiturates and beta-adrenoceptor antagonists.

Authors:  A Bast; P A Goossens; E M Savenije-Chapel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Apr-Jun       Impact factor: 2.441

2.  Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital.

Authors:  G Heinemeyer; H J Gramm; W Simgen; R Dennhardt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Intra-arterial administration of hexobarbital enantiomers to the rat: disposition and estimation of apparent extraction ratio.

Authors:  M Van der Graaff; N P Vermeulen; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1986-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.